Topics

Merck KGaA invests in state-of-the-art #biotech development facility in Switzerland https://www.merckgroup.com/en/news/2020-01-27-biotech-development-center.html …

09:34 EST 31 Jan 2020 | Genetic Engineering News

Merck KGaA invests in state-of-the-art development facility in Switzerland https://www.merckgroup.com/en/news/2020-01-27-biotech-development-center.html …

Original Article: Merck KGaA invests in state-of-the-art #biotech development facility in Switzerland https://www.merckgroup.com/en/news/2020-01-27-biotech-development-center.html …

NEXT ARTICLE

More From BioPortfolio on "Merck KGaA invests in state-of-the-art #biotech development facility in Switzerland https://www.merckgroup.com/en/news/2020-01-27-biotech-development-center.html …"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...